BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9520949)

  • 1. Elevated c-Src protein expression is an early event in colonic neoplasia.
    Iravani S; Mao W; Fu L; Karl R; Yeatman T; Jove R; Coppola D
    Lab Invest; 1998 Mar; 78(3):365-71. PubMed ID: 9520949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activation of pp60(c-src) and pp62(c-yes) in human colorectal carcinoma liver metastases.
    Han NM; Curley SA; Gallick GE
    Clin Cancer Res; 1996 Aug; 2(8):1397-404. PubMed ID: 9816313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific differences in pp60c-src activity in human colorectal metastases.
    Termuhlen PM; Curley SA; Talamonti MS; Saboorian MH; Gallick GE
    J Surg Res; 1993 Apr; 54(4):293-8. PubMed ID: 7687314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis.
    Ciaparrone M; Yamamoto H; Yao Y; Sgambato A; Cattoretti G; Tomita N; Monden T; Rotterdam H; Weinstein IB
    Cancer Res; 1998 Jan; 58(1):114-22. PubMed ID: 9426067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced C-terminal Src kinase (Csk) activities in hepatocellular carcinoma.
    Masaki T; Okada M; Tokuda M; Shiratori Y; Hatase O; Shirai M; Nishioka M; Omata M
    Hepatology; 1999 Feb; 29(2):379-84. PubMed ID: 9918913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis.
    Aligayer H; Boyd DD; Heiss MM; Abdalla EK; Curley SA; Gallick GE
    Cancer; 2002 Jan; 94(2):344-51. PubMed ID: 11900220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of N-myristoyltransferase inhibitor protein and its relationship to c-Src levels in human colon cancer cell lines.
    Rajala RV; Dehm S; Bi X; Bonham K; Sharma RK
    Biochem Biophys Res Commun; 2000 Jul; 273(3):1116-20. PubMed ID: 10891381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene-mediated transformation of fetal rat colon in vitro.
    Pories S; Jaros K; Steele G; Pauley A; Summerhayes IC
    Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of serum amyloid A, in normal, dysplastic, and neoplastic human colonic mucosa: implication for a role in colonic tumorigenesis.
    Gutfeld O; Prus D; Ackerman Z; Dishon S; Linke RP; Levin M; Urieli-Shoval S
    J Histochem Cytochem; 2006 Jan; 54(1):63-73. PubMed ID: 16116035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
    Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
    Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Yes tyrosine kinase activity in human colon carcinoma.
    Park J; Meisler AI; Cartwright CA
    Oncogene; 1993 Oct; 8(10):2627-35. PubMed ID: 7690925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
    Greco C; Alvino S; Buglioni S; Assisi D; Lapenta R; Grassi A; Stigliano V; Mottolese M; Casale V
    Anticancer Res; 2001; 21(5):3185-92. PubMed ID: 11848471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells.
    Marchetti D; Parikh N; Sudol M; Gallick GE
    Oncogene; 1998 Jun; 16(25):3253-60. PubMed ID: 9681823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma.
    Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP
    Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
    Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
    Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An epitope localized in c-Src negative regulatory domain is a potential marker in early stage of colonic neoplasms.
    Sakai T; Kawakatsu H; Fujita M; Yano J; Owada MK
    Lab Invest; 1998 Feb; 78(2):219-25. PubMed ID: 9484720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon.
    D'Emilia J; Bulovas K; D'Ercole K; Wolf B; Steele G; Summerhayes IC
    Oncogene; 1989 Oct; 4(10):1233-9. PubMed ID: 2571966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of C-terminal src kinase in human colorectal cancer cell lines.
    Watanabe N; Matsuda S; Kuramochi S; Tsuzuku J; Yamamoto T; Endo K
    Jpn J Clin Oncol; 1995 Feb; 25(1):5-9. PubMed ID: 7533218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of pp60c-src in low grade human bladder carcinoma.
    Fanning P; Bulovas K; Saini KS; Libertino JA; Joyce AD; Summerhayes IC
    Cancer Res; 1992 Mar; 52(6):1457-62. PubMed ID: 1371716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of CD44 variant 6 expression and clinicopathological factors in pulmonary metastases from colon carcinoma.
    Indinnimeo M; Cicchini C; Giarnieri E; Stazi A; Mingazzini PL; Stipa V
    Oncol Rep; 2003; 10(6):1875-7. PubMed ID: 14534711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.